Skip to main content
SpringerLink
Log in

Association of Lipoprotein(a) and hsCRP Levels with Metabolic Syndrome and its Components

  • Original Article
  • Published:
Indian Journal of Clinical Biochemistry Aims and scope Submit manuscript

Abstract

Cardiovascular diseases (CVDs) deserve more clinical attention being the primary clinical outcome of metabolic syndrome (MetS). Indians are highly predisposed to MetS, insulin resistance and CVDs. The traditional and unconventional risk factors in circulation could prove to be of immense value in further CVD risk stratification. Lipoprotein(a) [Lp(a)] and high sensitivity CRP (hs-CRP) are among the emerging risk factors in the development of CVDs. But there is a dearth of such studies in Gujarat. Therefore the current study attempts to evaluate the levels of Lp(a) and hs-CRP in MetS and its components in population of Jamnagar district, Gujarat. This cross-sectional study comprised 222 subjects of both genders attending OPD and IPD of Guru Gobind Singh Government Hospital, Jamnagar. The modified NCEP ATPIII criteria were used to diagnose participants with MetS. Various anthropometric measurements were recorded as per standard protocol. 5 ml overnight fasting blood samples were collected for the analyses of various biochemical parameters. A significantly higher BMI, W/H ratio, systolic & diastolic BP (SBP & DBP) and lipid profile were observed in MetS. The association between the presence of MetS and Lp(a) was found to be significant (χ 2 = 26.60; p < 0.0001). Elevated fasting blood glucose presented with the highest risk of causing an elevation in Lp(a) levels (OR = 2.369; CI = 1.087, 5.163; p = 0.03) in this study on multivariate regression analysis. Multivariate analysis also showed hs-CRP as a strong risk factor (OR = 3.18; CI = 1.236, 8.217; p = 0.016) for developing MetS. Thus Lp(a) and hs-CRP investigations are recommended in MetS subjects for defining preventive strategies against future coronary events.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Reaven GM. Role of insulin resistance in human disease. Diabetes. 1988;37:1595–607.

    Article  CAS  PubMed  Google Scholar 

  2. Grundy SM. The metabolic syndrome pandemic. Arterioscler Thromb Vasc Biol. 2008;28:629–36.

    Article  CAS  PubMed  Google Scholar 

  3. Enas EA, Yusuf S, Mehta J. Prevalence of coronary artery disease in Asian Indians. Am J Cardiol. 1992;70:945–9.

    Article  CAS  PubMed  Google Scholar 

  4. Misra A, Vikram NK. Insulin Resistance Syndrome (Metabolic Syndrome) and Asian Indians. Curr Sci (special sect:diabetes). 2002;83:1483–96.

    CAS  Google Scholar 

  5. Misra A, Wasir JS, Pandey RM. An evaluation of candidate definitions of the metabolic syndrome in adult Asian Indians. Diabetes Care. 2005;28:398–403.

    Article  PubMed  Google Scholar 

  6. Grundy SM, Cleeman JI, Daniels SR, Donato K, Eckel RH, Franklin BA, et al. Diagnosis and management of the metabolic syndrome an American Heart Association/National Heart, Lung, and Blood Institute Scientific statement. Circulation. 2005;112:2735–52.

    Article  PubMed  Google Scholar 

  7. Berg K. A new serum type system in man: the LP system. Acta Pathol Microbiol Scand. 1963;59:369–82.

    Article  CAS  PubMed  Google Scholar 

  8. Utermann G, Menzel HJ, Kraft HG, Duba HC, Kemmler HG, Seitz C. Lp(a) glycoprotein phenotypes. Inheritance and relation to Lp(a)-lipoprotein concentrations in plasma. J Clin Invest. 1987;80(2):458–65.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  9. Jacobson TA. Lipoprotein(a), cardiovascular disease, and contemporary management. Mayo Clin Proc. 2013;88(11):1294–311.

    Article  CAS  PubMed  Google Scholar 

  10. Scanu AM, Lawn RM, Berg K. Lipoprotein(a) and atherosclerosis. Ann Intern Med. 1991;115:209–10.

    Article  CAS  PubMed  Google Scholar 

  11. Scanu AM. Lipoprotein(a) and the atherothrombotic process: mechanistic insights and clinical implications. Curr Atheroscler Rep. 2003;5(2):106–8.

    Article  PubMed  Google Scholar 

  12. Mana S, Koschinsky M. Lipoprotein(a) as a risk factor for coronary artery disease. Am J Cardiol. 1998;82:57U–66U.

    Article  Google Scholar 

  13. Anuurad E, Boffa M, Koschinsky M, Berglund L. Lipoprotein(a): a unique risk factor for cardiovascular disease. Clin Lab Med. 2006;26:751–72.

    Article  PubMed  Google Scholar 

  14. Poon M, Zhang X, Dunsky K, Taubman M, Harpel P. Apolipoprotein(a) induces monocyte chemotactic activity in human vascular endothelial cells. Circulation. 1997;96:2514–6.

    Article  CAS  PubMed  Google Scholar 

  15. Rifai N, Ma J, Sacks FM, Ridker PM, Hernandez W, Stampfer M, et al. Apolipoprotein(a) size and lipoprotein(a) concentration and future risk of angina pectoris with evidence of severe coronary atherosclerosis in men: the physicians health study. Clin Chem. 2004;50(8):1364–8.

    Article  CAS  PubMed  Google Scholar 

  16. Bostom AG, Cupples LA, Jenner JL, Ordovas JM, Seman LJ, Wilson PW, et al. Elevated plasma lipoprotein [a] and coronary heart disease in men aged 55 years and younger: a prospective study. J Am Med Assoc. 1996;276:544–5.

    Article  CAS  Google Scholar 

  17. Eapen D, Kalra GL, Merchant N, Arora A, Khan BV. Metabolic syndrome and cardiovascular disease in South Asians. Vasc Health Risk Manag. 2009;5:731–43.

    PubMed Central  PubMed  Google Scholar 

  18. Ridker PM. Clinical application of C-reactive protein for cardiovascular disease detection and prevention. Circulation. 2003;107:363–7.

    Article  PubMed  Google Scholar 

  19. Ridker PM. High-sensitivity C-reactive protein and cardiovascular risk: rationale for screening and primary prevention. Am J Cardiol. 2003;92S:17k–22k.

    Article  Google Scholar 

  20. Rost NS, Wolf PA, Kase CS, Kelly-Hayes M, Silbershatz H, Massaro JM, et al. Plasma concentration of creactive protein and risk of ischemic stroke and transient ischemic attack: the Framingham study. Stroke. 2001;32:2575–9.

    Article  CAS  PubMed  Google Scholar 

  21. Mohan V, Shanthirani S, Deepa R, Premlatha G, Sastry NG, Saroja R. Intra-urban differences in the prevalence of metabolic syndrome in Southern India-the Chennai Urban Population Study (CUPS No 4). Diabet Med. 2001;18(4):280–8.

    Article  CAS  PubMed  Google Scholar 

  22. Prasad DS, Kabir Z, Dash AK, Das BC. Prevalence and risk factors for metabolic syndrome in Asian Indians: a community study from urban Eastern India. J Cardiovasc Dis Res. 2012;3(3):204–8.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  23. Tyagi H, Modgil V, Nath M. Metabolic syndrome: the prevalence of mounting public health problem in Ghaziabad India. JPAST. 2013;3(2):86–8.

    Google Scholar 

  24. Despre´s JP. Abdominal obesity: the most prevalent cause of the metabolic syndrome and related cardiometabolic risk(B). Eur Heart J Suppl. 2006;8:B4–9.

    Article  Google Scholar 

  25. Sawant A, Mankeshwar R, Shah S, Raghavan R, Dhongde G, Raje H, D’souza S, et al. Prevalence of metabolic syndrome in urban India. Cholesterol. 2011;2011:1–7.

    Article  Google Scholar 

  26. Bermúdez V, Rojas J, Salazar J, Bello L, Áñez R, Toledo A, et al. Variations of lipoprotein(a) levels in the metabolic syndrome: a report from the Maracaibo city metabolic syndrome prevalence study. J Diabetes Res. 2013;2013:1–13.

    Article  Google Scholar 

  27. Roberts CK, Bernard RJ. Effects of exercise and diet on chronic disease. J Appl Physiol. 2005;98:3–30.

    Article  PubMed  Google Scholar 

  28. Grundy SM. Hypertriglyceridemia, insulin resistance and Metabolic syndrome. Am J Cardiol. 1999;83:25F–9F.

    Article  CAS  PubMed  Google Scholar 

  29. Liu S, Manson JE, Buring JE, Stampfer MJ, Willett WC, Ridker PM. Relation between a diet with high glycemic load and plasma concentrations of high-sensitivity C-reactive protein in middle aged women. Am J Clin Nutr. 2002;75:492–7.

    CAS  PubMed  Google Scholar 

Download references

Acknowledgments

The study was financially supported by Indian Council of Medical Research (ICMR) and we express our acknowledgements to ICMR for the same. We are thankful to all those who participated in this study.

Conflict of Interests

There are no financial or other contractual agreements that might cause conflict of interests.

Author information

Authors and Affiliations

  1. Department of Biochemistry, M.P. Shah Government Medical College, Jamnagar, 361008, Gujarat, India

    Bijoya Chatterjee, Tejas Shah, Hardik Mahant, Vandana Katwa & Ketangiri Gosai

  2. Department of Medicine, M.P. Shah Government Medical College, Jamnagar, 361008, Gujarat, India

    Manish Mehta

Authors
  1. Bijoya Chatterjee
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Manish Mehta
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Tejas Shah
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Hardik Mahant
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Vandana Katwa
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Ketangiri Gosai
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Bijoya Chatterjee.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Chatterjee, B., Mehta, M., Shah, T. et al. Association of Lipoprotein(a) and hsCRP Levels with Metabolic Syndrome and its Components. Ind J Clin Biochem 30, 394–402 (2015). https://doi.org/10.1007/s12291-014-0473-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12291-014-0473-x

Keywords

Search

Navigation